Latest filing published 23 Mar 2016 for CTI Biopharma CORP, €31k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Matthew Plunkett: trading record in brief
This profile gathers the share dealings of Matthew Plunkett in CTI Biopharma Corp. In total, 298 filings cover trades dated from 16 October 2012 to 21 March 2016.
Sales make up the whole of the open-market record (290 sales, €1.4M). Outside the open market, there are 8 share grants. So far in 2016, the count stands at no purchases and 28 sales.
Most recently, on 23 March 2016, the filings show a share grant worth €31k in CTI Biopharma Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Plunkett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 63,874 shares@ US$0.548253.5% of flowCommon StockSEC:0000891293-16-000135:0
- 1,300 shares@ US$0.5851.2% of flowCommon StockSEC:0000891293-16-000113:0
- 400 shares@ US$0.5860.4% of flowCommon StockSEC:0000891293-16-000113:1
- 636 shares@ US$0.5870.6% of flowCommon StockSEC:0000891293-16-000113:2
- 1,500 shares@ US$0.5881.4% of flowCommon StockSEC:0000891293-16-000113:3
- 844 shares@ US$0.5890.8% of flowCommon StockSEC:0000891293-16-000113:4
- 700 shares@ US$0.590.7% of flowCommon StockSEC:0000891293-16-000113:5
- 700 shares@ US$0.5910.7% of flowCommon StockSEC:0000891293-16-000113:6
- 200 shares@ US$0.5920.2% of flowCommon StockSEC:0000891293-16-000113:7
- 1,100 shares@ US$0.5931.0% of flowCommon StockSEC:0000891293-16-000113:8
- 500 shares@ US$0.5940.5% of flowCommon StockSEC:0000891293-16-000113:9
- 1,220 shares@ US$0.5951.1% of flowCommon StockSEC:0000891293-16-000113:10
- 900 shares@ US$0.5960.8% of flowCommon StockSEC:0000891293-16-000113:11
- 5,000 shares@ US$1.1524.0% of flowCommon StockSEC:0000891293-16-000094:1
- 3,000 shares@ US$1.15514.5% of flowCommon StockSEC:0000891293-16-000094:2
- 600 shares@ US$1.162.9% of flowCommon StockSEC:0000891293-16-000094:3
- 300 shares@ US$1.1751.5% of flowCommon StockSEC:0000891293-16-000094:5
- 700 shares@ US$1.173.4% of flowCommon StockSEC:0000891293-16-000094:4
- 400 shares@ US$1.141.9% of flowCommon StockSEC:0000891293-16-000094:0
- 1,900 shares@ US$1.219.8% of flowCommon StockSEC:0000891293-16-000079:3
- 202 shares@ US$1.241.1% of flowCommon StockSEC:0000891293-16-000079:7
- 1,600 shares@ US$1.1958.2% of flowCommon StockSEC:0000891293-16-000079:0
- 1,898 shares@ US$1.209.7% of flowCommon StockSEC:0000891293-16-000079:1
- 800 shares@ US$1.234.2% of flowCommon StockSEC:0000891293-16-000079:5
- 800 shares@ US$1.2054.1% of flowCommon StockSEC:0000891293-16-000079:2
25 of 297 declarations
